SNDX SYNDAX PHARMACEUTICALS INC Management Changes 8-K Filing 2025 - Appointments On May 12, 2025, Syndax Pharmaceuticals appointed Nicholas A.J. Botwood as Chief Medical Officer and Head of Research, replacing Neil Gallagher who resigned; Botwood's salary is $540,000 with a bonus target of 45% and stock options for 215,000 shares.Get access to all SEC 8-K filings of the SYNDAX PHARMACEUTICALS INC